Stereotaxis (STXS) 8-K Regulation FD Disclosure

Exhibit 99.1

STEREOTAXIS, INC.

BALANCE SHEET

UNAUDITED ACTUAL AND AS ADJUSTED

JUNE 30, 2019

	June 30, 2019 as reported			Adjustments as a result of August financing			June 30, 2019 including August financing
	(Unaudited)			(Unaudited)			(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	8,471,914		$	23,130,000	(1)	$	31,601,914
Accounts receivable, net of allowance of $502,251		4,997,148						4,997,148
Inventories, net		1,560,116						1,560,116
Prepaid expenses and other current assets		514,408						514,408
Total current assets		15,543,586			23,130,000			38,673,586
Property and equipment, net		297,494						297,494
Operating lease right-of-use assets		5,245,842						5,245,842
Other assets		168,153						168,153
Total assets	$	21,255,075		$	23,130,000		$	44,385,075
Liabilities and stockholders’ equity (deficit)
Current liabilities:
Accounts payable	$	1,642,049					$	1,642,049
Accrued liabilities		2,376,058						2,376,058
Deferred revenue		6,537,988						6,537,988
Current portion of operating lease liabilities		2,223,023						2,223,023
Total current liabilities		12,779,118			-			12,779,118
Long-term deferred revenue		508,772						508,772
Operating lease liabilities		3,048,650						3,048,650
Other liabilities		260,947						260,947
Total liabilities		16,597,487			-			16,597,487
Convertible preferred stock (10,000,000 shares authorized):
Convertible preferred stock, par value $0.001; Series A, 23,855 shares outstanding		5,948,953						5,948,953
Stockholders’ equity (deficit):
Common stock, par value $0.001; 300,000,000 shares authorized, 59,383,038 issued at 6/30/19 as reported and 65,968,038 issued at 6/30/19 as adjusted		59,383			6,585	(2)		65,968
Convertible preferred stock, par value $0.001; Series B, 0 shares outstanding at 6/30/19 as reported, 5,610,121 shares outstanding at 6/30/19 as adjusted		-			5,610	(3)		5,610
Additional paid-in capital		479,127,279			23,117,805	(1)		502,245,084
Treasury stock, 4,015 shares		(205,999	)					(205,999	)
Accumulated deficit		(480,272,028	)					(480,272,028	)
Total stockholders’ equity (deficit)		(1,291,365	)		23,130,000			21,838,635
Total liabilities and stockholders’ equity (deficit)	$	21,255,075		$	23,130,000		$	44,385,075

(1) Effect of sale of (i) 6,585,000 shares of the Company’s common stock and (ii) 5,610,121 shares of the Company’s Series B Convertible Preferred Stock, in each case at a price of $2.05 per share (the “Private Placement”), net of expenses.

(2) Effect of issuance of 6,585,000 shares of the Company’s common stock in the Private Placement.

(3) Effect of issuance of 5,610,121 shares of the Company’s Series B Convertible Preferred Stock in the Private Placement.